Drug Shortage Report for APO-GLICLAZIDE MR
| Report ID | 127342 |
| Drug Identification Number | 02297795 |
| Brand name | APO-GLICLAZIDE MR |
| Common or Proper name | GLICLAZIDE |
| Company Name | APOTEX INC |
| Market Status | MARKETED |
| Active Ingredient(s) | GLICLAZIDE |
| Strength(s) | 30MG |
| Dosage form(s) | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 100 BTL |
| ATC code | A10BB |
| ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2020-10-26 |
| Estimated end date | 2021-03-05 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2020-12-28 |
| Company comments | |
| Health Canada comments | |
| Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
| Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.